Metropolis Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has sought shareholder approval via postal ballot (remote e-voting from May 16 to June 14, 2025) for three board-level appointments. Resolution 1 seeks approval to appoint Ms. Purvi Sheth (HR strategist, board member of Shoppers Stop, Ambuja Cements, Kirloskar Industries) as a Non-Executive Independent Director for a 5-year term starting March 17, 2025. Resolution 2 seeks approval to appoint Mr. Rehan Khan (currently MD of MSD India, former MD of Abbott India, Harvard Business School alumnus) as a Non-Executive Independent Director for a 5-year term starting May 13, 2025. Resolution 3 seeks approval to elevate the current CEO, Mr. Surendran Chemmenkotil, to Managing Director for a 3-year term effective June 1, 2025 to May 31, 2028, with a fixed annual salary of ₹4.44 crore, variable pay of ₹85 lakh, and perquisites of ₹63 lakh.
The transition elevates the sitting CEO to Managing Director, providing leadership continuity while adding two high-profile independent directors with deep healthcare and HR expertise. For shareholders, the key watchpoint is Mr. Chemmenkotil's total compensation package of nearly ₹6 crore annually plus 1,08,000 outstanding RSUs; investor focus will be on whether the e-voting results (due by June 16, 2025) draw significant dissent, particularly on the MD remuneration.